AWARE™ BED™ EIA DBS CONTROL PACK
HIV Incidence Test
The Aware™ BED™ EIA HIV-1 Incidence test can test spots prepared from dried serum, plasma and whole blood with the use of the supplemental Aware™ BED™ EIA DBS Control Pack. The ability to test dried specimens is important because it allows the inclusion of samples collected in hot or remote locations and the testing of archived dried samples.
The Aware™ BED™ EIA DBS Control Pack contains quality-control reagents for use only with the Aware™ BED™ EIA test. The dried blood spot controls should be used as quality control reagents in place of the liquid controls and calibrator only when dried serum, dried plasma or dried whole-blood spots are to be tested. If liquid serum, plasma or whole-blood specimens are to be tested, the liquid controls provided with the EIA should be used.
Product Highlights
- Protocol for testing dried specimens developed and tested by United States Centers for Disease Control and Prevention
- Testing of dried specimens uses the standard Aware™ BED™ EIA with only protocol modification related to use of dedicated controls and sample preparation (elution)
- Tests dried specimens prepared from serum, plasma or whole blood; all dried specimen types use the same assay protocol
- Excellent concordance of dried specimens to liquid specimens
- Facilitates incidence testing of samples collected in hot and remote locations
- Allows for retrospective incidence testing of archived dried blood, serum and plasma samples
- The three controls spots and the single calibrator spot are color coded for ease of use
Configurations
| Product description | Quantity | Catalog number | Product insert |
| DBS Control Pack | 20 DBS cards | 98133 | English |
Product literature / downloads
Calypte Biomedical Corporation develops
point-of-care diagnostic HIV tests
and HIV incidence testing systems.
The Calypte Aware™
rapid oral fluid HIV test,
blood HIV test, and urine HIV test offer unrivalled
rapid HIV 1/2 testing flexibility in a non-laboratory setting.